Autophagy Induction After Bortezomib for Myeloma

NCT01594242 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Bortezomib

Sponsor

Abramson Cancer Center at Penn Medicine